Microbial Fermentation APIs Market will reach 31000 million US$ by the end of 2025

This report studies the global Microbial Fermentation APIs market status and forecast, categorizes the global Microbial Fermentation APIs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.

Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).

Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).

With developed pharmaceuticals industry, Europe, USA and Japan are the major consumption markets of microbial fermentation APIs. These international pharmaceuticals giants generally purchase APIs from Asia, especially China and India.

Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/100131/global-microbial-fermentation-apis-market

China is the emerging consumption market of microbial fermentation APIs and it is also the largest supplier. In the market of antibiotics and vitamin, China have occupied market share of more than half. With foreign based plants and local manufacturers, India is another major supplier of APIs.

Antibiotics enjoyed the largest market share of microbial fermentation APIs, and China is the largest supplier with production of about 150 K MT. Amino acids are another important parts of microbial fermentation APIs market. Among these amino acids, the amount of glutamic acid and l-lysine are at most.

The global Microbial Fermentation APIs market is valued at 27700 million US$ in 2017 and will reach 31000 million US$ by the end of 2025, growing at a CAGR of 1.4% during 2018-2025.

The major manufacturers covered in this report

Merck

Ajinomoto

HGPF

Huaxing

North China Pharmaceutical

Topfond

DSM

Tianyao

CSPC Pharma

Northeast Pharm

Lukang Pharmaceutical

Luwei Pharmaceutical

Jiangshan (DSM)

Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/100131/global-microbial-fermentation-apis-market

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America

Europe

China

Japan

Southeast Asia

India

About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA - 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – sales@qyresearch.com
Web – www.qyresearch.com
Expert News: https://www.qyresearch.com/expert/list

This release was published on openPR.